REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 31 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,066,000 | -59.1% | 7,500,000 | -46.4% | 0.03% | -63.0% |
| Q2 2023 | $14,826,000 | +140.8% | 14,000,000 | +180.0% | 0.07% | +135.5% |
| Q1 2023 | $6,157,500 | +2.6% | 5,000,000 | -23.1% | 0.03% | -29.5% |
| Q4 2022 | $5,999,500 | -45.0% | 6,500,000 | -35.0% | 0.04% | -33.3% |
| Q3 2022 | $10,900,000 | -0.8% | 10,000,000 | -25.9% | 0.07% | +22.2% |
| Q2 2022 | $10,986,000 | -24.7% | 13,500,000 | -12.9% | 0.05% | +35.0% |
| Q1 2022 | $14,580,000 | +6.5% | 15,500,000 | 0.0% | 0.04% | +73.9% |
| Q4 2021 | $13,688,000 | -20.9% | 15,500,000 | +3.3% | 0.02% | -32.4% |
| Q3 2021 | $17,301,000 | +18.1% | 15,000,000 | +20.0% | 0.03% | +3.0% |
| Q2 2021 | $14,646,000 | +85.9% | 12,500,000 | +78.6% | 0.03% | +43.5% |
| Q1 2021 | $7,880,000 | – | 7,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antara Capital LP | 49,500,000 | $47,535,000 | 1.45% |
| ZAZOVE ASSOCIATES LLC | 16,238,000 | $15,254,000 | 1.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 26,000,000 | $24,456,000 | 0.22% |
| WEDBUSH SECURITIES INC | 30,000 | $2,807,000 | 0.13% |
| AVIVA PLC | 15,000,000 | $14,034,000 | 0.07% |
| Context Capital Management, LLC | 1,000 | $951,000 | 0.06% |
| LMR Partners LLP | 4,500,000 | $4,242,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,500,000 | $14,580,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 27,770,000 | $26,121,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $45,150,000 | 0.02% |